Junshi Biosciences (01877) has announced the successful completion of its third technology innovation bond issuance for the 2026 fiscal year, with the raised funds credited to the company's account on August 21, 2026.
The total issuance amount reached 700 million yuan, carrying an annual interest rate of 2.55% and a maturity period of three years.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.